A public health perspective on global burden of HIV/AIDS in Russia: DALY due to HIV infection. Part 2
https://doi.org/10.22328/2077-9828-2025-17-2-32-43
Abstract
The aim. To evaluate age/gender differences in life losses and losses related to decrease in social and labor functioning, caused by HIV among population in Russia.
Materials and methods. In ecological study, losses caused by premature mortality adjusted for decrease in labor and social functioning (DALY), caused by HIV were calculated, using adapted methodology among men and women of different ages in Russia for 2016 and 2022. HIV morbidity and mortality data obtained from FEDERAL statistical observation forms were used.
Results and discussion. In Russia the DALY due to HIV decreased overall by 1.5 times in 2016–2022. In DALY structure, the YLL was prevailed among 35–44 age group and mostly in men, amounting to 1870.6 in 2016, and 1341.4 per 100 000 of corresponding age/gender population in 2022. Among women the YLD was prevailed, with the YLD/YLL ratio in 2016 being 1:1.5; in 2022 this ratio became equal. There is increase in the YLL and YLD among group aged 45 years and older. Among women and men of working past age, the YLL in 2016–2022 increased by 1.5 and 1.3 times respectively, when among women and men of working-age, the indicator, on the contrary, decreased by 1.1 and 1.2 times respectively. Among girls, the YLL in 2022 was more than 4 times (p < 0.001) higher, than similar indicators among young men.
Conclusion. Prevailing of losses caused by HIV/AIDS premature mortality (YLL) among working-age population is unfavorable factor, worsening public health quality in terms of preserving human resources, it indicates the need of strengthening measures to reduce HIV burden in country.
About the Authors
Z. M. Zagdyn
N. A. Semashko National Research Institute of Public Health
Russian Federation
Russian Federation
Moscow
N. V. Kobesov
Republic Clinical Center of pthisiopulmonology
Russian Federation
Russian Federation
Vladikavkaz
V. L. Denyushenkov
N. A. Semashko National Research Institute of Public Health
Russian Federation
Russian Federation
Moscow
S. A. Sterlikov
Russian Research Institute of Health
Russian Federation
Russian Federation
Moscow
References
1. Hoffman C. HIV 2023/2024. www.hivbook.com / еd. by C. Hoffman, J. K. Rockstroh. Humburg: Medizine Fokus Verlag, 2023. 712 p.
2. Onishchenko G.G., Popova A.Yu., Toporkov V.P., Smolenskiy V.Yu., Shcherbakova S.A., Kutyrev V.V. Present-Day Menaces and Challenges in the Sphere of Biological Safety and Strategy of Countermeasures. Problems of especially dangerous infections, 2015, Vol. 3, рр. 5–9 (In Russ.)
3. Nechayeva O.B. Socially important infectious diseases posing biological threat to the population of Russia. Tuberculosis and lung diseases, 2019, Vol. 97, No 11, рр. 7–17 (In Russ.). doi.org/10.21292/2075-1230-2019-97-11-7-17.
4. Zudin A.B., Shhepin V.O. Global challenges for the Russian healthcare. Bulletin of Semashko National Research Institute of Public Health, 2016, No 5, рр. 42–47 (In Russ.)
5. Epidemiological fact sheet. HIV statistics, globally and by WHO region. Geneva, 2023. Р. 8.
6. Global AIDS Monitoring, 2024. Geneva: Joint United Nations Programme on HIV/AIDS (https://aidsinfo.unaids.org/). Global AIDS Monitoring, 2024 GAM/IBBS.
7. HIV/AIDS surveillance in Europe 2023–2022 data. Stockholm: ECDC, 2023. doi: 10.2900/08930.
8. Korenromp E.L., Sabin K., Stover J., Brown T., Johnson L.F., Martin-Hughes R. et al. New HIV infections among key populations and their partners in 2010 and 2022, by world region: a multisources estimation // J. Acquir. Immune Defic. Syndr. 2024. Vol. 95, No. 1S. e34–e45. doi: 10.1097/QAI.0000000000003340.
9. Pokrovskiy V.V. Wait-and-see strategy. Epidemiology and infectious diseases, 2015, No. 1, рр. 4–9 (In Russ.).
10. Belyakov N.A., Rassokhin V.V., Bobreshova A.S. Counteraction to HIV infection and the growth of morbidity in Russia. HIV infection and immunosuppression, Vol. 9, No. 2, рр. 82–90 (In Russ.). doi: 10.22328/2077-9828-2017-9-2-82-90.
11. Adgamov R.R., Antonova A.A., Ogarkova D.A., Kuznetsova A.I., Pochtovyi A.A., Kleymenov D.A., Kuznetsova N.A., Siniavin A.E., Kaminskiy G.D., Tsyganova E.V., Gushchin V.A., Gintsburg A.L., Mazus A.I. HIV-infection in the Russian Federation: current diagnostic trends. HIV Infection and Immunosuppressive Disorders, 2024, Vol. 16, No. 1, рр. 45–59 (In Russ.). doi: 10.22328/2077-9828-2024-16-1-45-59.
12. Zagdyn Z.M., Kobesov N.V., Verbitskaya E.V., Denyushenkov V.L. Global burden of HIV/AIDS in Russia in the aspect of public health. Part 1. HIV Infection and Immunosuppressive Disorders, 2023, Vol. 16, No 2, рр. 69–80 (In Russ.). doi: 10.22328/2077-9828-2023-15-2-69-80.
13. Sterlikov S.A., Mikhaylova Yu.V., Golubev N.A., Gromov A.V., Kudrina V.G., Mikhaylov A.Yu. Mortality from major infectious and parasitic diseases: diseases caused by HIV, tuberculosis and parenteral viral hepatitis in the Russian Federation and its dynamics in 2015–2020. Current problems of health care and medical statistics, 2022, No. 3, рр. 40–65 (In Russ.). doi: 10.24412/2312-2935-2022-3-40-65.
14. Murray C.J.L. Quantifying the burden of disease: the technical basis for disability-ajusted life years // Bulletin of the World Health Organization. 1994. Vol. 72, No 3. P. 429–445.
15. Sultanbekova B., Akanov A., Kosherbaeva L., Karsakbaeva L. Global burden of diseases, injuries and risk factor. Medicine, 2015, No. 2 (152), рр. 11–13 (In Russ.).
16. Sabgayda T.P., Protasova N.P., Artuchov I.P. Adapting DALY calculation for analysis of health loss due to nonfatal cardiovascular diseases. Social aspects of population health, 2015, No. 1, рр. 41 (In Russ.).
17. WHO methods and data sources for global burden of disease estimates 2000–2019. Department of Data and Analytics Data, Analytics and Delivery Department for Impact. World Health Organization. Geneva. 2020. https://cdn.who.int/media/docs/default-source/ghodocuments/global-health-estimates/ghe2019_daly-methods.pdf
18. GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 // Lancet. 2017. Vol. 390. P. 1151–1210. doi: 10.1016/S0140-6736(17)32152-9.
19. GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 // Lancet. 2024. Vol. 403. P. 2133–2161. doi:10.1016/S0140-6736(24)00757-8.
20. Liu W., Wang W., Liu J., Liu Y., Meng S., Wang F., Long Z., Qi J., You J., Lin L., Wang L, Zhou M., Yin P. Trend of Mortality and Years of Life Lost Due to Chronic Obstructive Pulmonary Disease in China and Its Provinces, 2005–2020 // Int. J. Chron. Obstruct Pulmon Dis. 2021. Vol. 16. P. 2973–2981. doi: 10.2147/COPD.S330792.
21. Deng P, Chen M, Si l. Temporal trends in inequalities of the burden of HIV/AIDS across 186 countries and territories // BMC Public Health. 2023. Vol. 23, No 1. 981. doi: 10.1186/s12889-023-15873-8.
22. Bermudez-Tamayo C., Martin J.J., Ruiz-Pérez I., Lima A.O. Factors associated with improvement in disability-adjusted life years in patients with HIV/AIDS // BMC Public Health. 2008. Vol. 8. 362. http://www.biomedcentral.com/1471-2458/8/362.
23. Grover G., Chakravarty S., Aggarwal S., Deo V. Estimating Disability Adjusted Life Years using Survival Models in HIV/AIDS Risk Groups // J. Commun. Dis. 2021. Vol. 53, No 4. P. 36–47. doi: 10.1186/1471-2458-8-362.
24. Yaghoobi H., Ahmadinia H., Shabani Z., Vazirinejad R., Safari R., Shahizadeh R., Zolfizadeh F., Rezaeian M. Life expectancy and years of life lost in HIV patients under the care of BandarAbbas Behavioral Disorders Counseling Center // Nepal. J. Epidemiol. 2017. Vol. 7, No 4. P. 702–712. doi: 10.3126/nje.v7i4.20627.
25. Luo Q., Pfeiffer R.M., Noone A.M., Horner M.J., Engels E.A., Shiels M.S. Years of life lost to cancer among the United States HIV population, 2006–2015 // AIDS. 2022. Vol. 36, No 9. P. 1279–1286. doi: 10.1097/QAD.0000000000003249.
26. Romanov G.N., Rudenko E.V., Platoshkin E.N., Romaniva O.A. Secondary prevention of osteoporotic fractures in the Republic of Belarus: DALY analysis and costeffectiveness. Problems of Health and Ecology. 2022. Vol. 19, No 4. P. 120–127 (In Russ.). doi: 10.51523/2708-6011.2022-19-4-16.
27. Kerimbai B.S., Murat M.S., Mauletova S.D., Shorman S. Estimation of the burden of syphilis using disability adjusted life years (DALY) in Kazakhstan. Pharmacy of Kazakhstan, 2023, Vol. 246, No 1, рр. 139–142 (In Russ.). doi: 10.53511/PHARMKAZ.2023.57.17.020.
28. Kobyakova O.S., Deev I.A., Kulikov E.S., Milkevich E.N., Boykov V.A., Shibalkov I.P., Nesvetailo N.Ya., Taranov A.A., Golubeva A.A., Baranovskaya S.V., Son I.M., Nedospasova O.P. Application of the DALY index to assess the health status of the population. Tomsk: SibSMU, 2020. 100 р. (In Russ.).
29. Tulenkov A.M. DALY as a comprehensive assessment of health status of prisoners in the Volga Federal District. Social aspects of population health, 2017, Vol. 54, No 2, р. 8 (In Russ.). doi: 10.21045/2071-5021-2017-54-2-8.
30. Barinova A.N., Lebedeva A.A., Ladnaya N.N., Zaytseva E.E., Plavinskii S.L. Estimating burden of disease due to continuous propagation of HIV infection among injecting drug users. HIV infection and immunosuppression, 2020, Vol. 12, No 1, рр. 97–104 (In Russ.). doi: 10.22328/2077-9828-2020-12-1-97-104.
31. Blokh A.I., Pasechnik O.A. The burden of disease and potential life loss due to HIV infection. HIV Infection and Immunosuppressive Disorders, 2017, Vol. 9, No 3, рр. 91–97 (In Russ.). doi: 10.22328/2077-9828-2017-9-3-91-97.
32. Zagdyn Z.M., Kobesov N.V., Pagieva M.K., Vasiliev M.D., Galoyan A.S. Gender-age peculiarities of disability-adjusted life years (DALY) for tuberculosis in a high-density region: a retrospective cohort study // Kuban Scientific Medical Bulletin. 2024. Vol. 31, No 2. P. 27–40. doi: 10.25207/1608-6228-2024-31-2-27-40.
33. Wu J., Lai T., Han H., Liu J., Wang S., Lyu J. Global, regional and national disability-adjusted life years due to HIV from 1990 to 2019: findings from the Global Burden of Disease Study 2019 // Trop. Med. Int. Health. 2021. Vol. 26, No 6. P. 610–620. doi: 0.1111/tmi.13565.
34. Tian X., Chen J., Wang X., Xie Y., Zhang X., Han D., Fu H., Yin W., Wu N. Global, regional, and national HIV/AIDS disease burden levels and trends in 1990–2019: A systematic analysis for the global burden of disease 2019 study // Front. Public Health. 2023. Vol. 11. 1068664. doi: 10.3389/fpubh.2023.1068664.
35. Vollset S.E., Ababneh H.S., Abate Y.H., Abbafati C., Abbasgholizadeh R., Abbasian M. et al. Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2022 // The Lancet. 2024. Vol. 403. P. 2204–2256. doi: 10.1016/S0140-6736(24)00685-8.
36. Kravchenko A.V., Ladnaia N.N., Pokrovsky V.V., Kozyrina N.V., Yurin O.G., Sokolova E.V., Chekryzhova D.G. Causes of death in people infected with the human immunodeficiency virus. Epidemiology and Infectious Diseases, Vol. 13, Nо. 3, рр. 56–63 (In Russ). doi: 10.18565/epidem.2023.13.3.56-63.
Review
For citations:
Zagdyn Z.M., Kobesov N.V., Denyushenkov V.L., Sterlikov S.A. A public health perspective on global burden of HIV/AIDS in Russia: DALY due to HIV infection. Part 2. HIV Infection and Immunosuppressive Disorders. 2025;17(2):32-43. (In Russ.) https://doi.org/10.22328/2077-9828-2025-17-2-32-43
Views:
21
.png)
Email this article 